Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase Ii trial
Kavanagh, J.J.; Wharton, J.T.; Rutledge, F.N.
Cancer Treatment Reports 68(11): 1417-1418
1984
ISSN/ISBN: 0361-5960 PMID: 6498856 Document Number: 230017
Document emailed within 1 workday
Related Documents
Kavanagh, J.J.; Gershenson, D.M.; Copeland, L.J.; Wharton, J.T.; Rutledge, F.N.; Krakoff, I.H. 1984: Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase Ii trial Cancer Treatment Reports 68(12): 1503-1504Kavanagh, J.J.; Copeland, L.; Gershenson, D.; Roberts, W. 1987: Continuous-infusion vinblastine for treatment of refractory adenocarcinoma of the cervix Cancer Treatment Reports 71(5): 547-548
Dexeus, F.; Logothetis, C.J.; Samuels, M.L.; Hossan, E.; von Eschenbach, A.C. 1985: Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer Cancer Treatment Reports 69(7-8): 885-886
Shah, M.K.; St Marie, K.; Catalano, R.B.; Dierks, K.; Creech, R.H. 1985: Phase Ii study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma Cancer Treatment Reports 69(2): 229-230
Coonley, C.J.; Warrell, R.P.; Young, C.W. 1983: Phase i trial of homoharringtonine administered as a 5-day continuous infusion Cancer Treatment Reports 67(7-8): 693-696
Weiss, G.R.; Ervin, T.J.; Meshad, M.W.; Kufe, D.W. 1982: Phase Ii trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU Cancer Treatment Reports 66(2): 299-303
Remick, S.C.; Grem, J.L.; Fischer, P.H.; Tutsch, K.D.; Alberti, D.B.; Nieting, L.M.; Tombes, M.B.; Bruggink, J.; Willson, J.K.; Trump, D.L. 1990: Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion Cancer Research 50(9): 2667-2672
Young, C.W.; Fanucchi, M.P.; Declan Walsh, T.; Baltzer, L.; Yaldaei, S.; Stevens, Y.W.; Gordon, C.; Tong, W.; Rifkind, R.A.; Marks, P.A. 1988: Phase i trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals Cancer Research 48(24 Part 1): 7304-7309
Lu, K.; Yap, H.Y.; Loo, T.L. 1983: Clinical pharmacokinetics of vinblastine by continuous intravenous infusion Cancer Research 43(3): 1405-1408
Takezako, Y.; Okusaka, T.; Ueno, H.; Ikeda, M.; Morizane, C.; Najima, M. 2008: Phase Ii study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC) Hepato-Gastroenterology 55(85): 1380-1384
Benson, A.B.; Trump, D.L.; Koeller, J.M.; Egorin, M.I.; Olman, E.A.; Witte, R.S.; Davis, T.E.; Tormey, D.C. 1985: Phase i study of vinblastine and verapamil given by concurrent iv infusion Cancer Treatment Reports 69(7-8): 795-799
Dorval, T.; Beuzeboc, P.; Garcia-Giralt, E.; Jouve, M.; Livartowski, A.; Palangie, T.; Pouillart, P. 1993: Treatment of cancers of the ovary. Phase Ii trial of increase of the dose of cisplatin Presse Medicale 22(3): 104-108
Sörenson, S.; Hansen, H.H.; Dombernowsky, P. 1976: Phase Ii study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung Cancer Treatment Reports 60(9): 1263-1266
Seibert, K.; Golub, G.; Smiledge, P.; Nystrom, J.S. 1979: Continuous streptozotocin infusion: a phase i study Cancer Treatment Reports 63(11-12): 2035-2037
Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W. 2000: Phase Ii study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer European Journal of Gynaecological Oncology 21(6): 610-612
Li, J.-h.; Li, B.; Jiang, H.-r.; Zhong, M.-z. 2011: Weekly regimen of paclitaxel liposome combined with cisplatin and 5-fluorouracil continuous infusion in the treatment of advanced gastric carcinoma Zhonghua Zhong Liu Za Zhi 33(3): 229-231
Carnino, F.; Guercio, E.; Cottini, M.; Gatti, M. 1984: Follow-up and second-look in epithelial carcinoma of the ovary Minerva Ginecologica 36(4): 205-208
Lokich, J.; Corkery, J. 1981: Phase i study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion Cancer Treatment Reports 65(9-10): 887-889
Cottini, M.; Carnino, F.; Iskra, L.; Rapisarda, V.; Mossetti, C. 1986: Tumor markers in epithelial carcinoma of the ovary Minerva Ginecologica 38(6): 479-484
Lomen, P.L.; Baker, L.H.; Neil, G.L.; Samson, M.K. 1975: Phase i study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days Cancer ChemoTherapy Reports 59(6): 1123-1126